pelareorep, Tecentriq 840 mg concentrate for solution for infusion
REO 029
Phase 2 small_molecule active
Quick answer
pelareorep, Tecentriq 840 mg concentrate for solution for infusion for Patients with advanced or metastatic gastrointestinal (GI) tumors. is a Phase 2 program (small_molecule) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ONCOLYTICS BIOTECH INC
- Indication
- Patients with advanced or metastatic gastrointestinal (GI) tumors.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active